TCL Archive Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months September 26, 2014
TCL Archive FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer February 21, 2003
TCL Archive New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds June 28, 2002
TCL Archive NCI plans 18 percent budget cuts for large R01s, smaller cuts to other research project grants. NCI treatment division director Ellen Feigal accepts position with Translational Genomics Research Institute in Phoeniz, Ariz. March 12, 2004
